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Abstract—Electronic health record is an important source for
clinical researches and applications, and errors inevitably occur
in the data, which lead to severe damages to both patients and
hospital services. One of such errors is the mismatch between
diagnose and prescription, which we address as “medication
anomaly” in the paper, and clinicians used to manually identify
and correct them. With the development of machine learning
techniques, researchers are able to train specific model for the
task, but the process still requires expert knowledge to construct
proper features, and few semantic relations are considered. In
this paper, we propose a simple, yet effective detection method
that tackles the problem by detecting the semantic inconsistency
between diagnoses and prescriptions. Unlike traditional outlier
or anomaly detection, the scheme uses continuous bag of words
to construct the semantic connection between specific central
words and their surrounding context. The detection of medica-
tion anomaly is transformed into identifying the least possible
central word based on given context. To help distinguish the
anomaly from normal context, we also incorporate a ranking
accumulation strategy. The experiments were conducted on two
real hospital electronic medical records, and the topN accuracy
of the proposed method increased by 3.91 to 10.91% and 0.68 to
2.13% on the datasets, respectively, which is highly competitive
to other traditional machine learning-based approaches.
Index Terms—Electronic health record, Medication misuse,
Diagnostic error, Semantic consistency, Continuous bag of word
I. INTRODUCTION
Electronic Health Record (EHR), is first motivated to curb
the trend of increasing cost in health and medical care [1],
[2]. It contains patients’ information like physical conditions,
diagnoses, prescriptions, and is considered to have the greatest
potential in elevating medical services.
Despite the fact that EHRs save considerable amount of
financial cost, to use such records will have to deal with errors
like unintended or wrong prescriptions [3], which sometimes
cause severe damages for not only patients themselves, but also
to hospital services. Table I is an example from a patient’s
EHR file. It can be noted that some of the medications
is irrelevant to the diagnoses. For example, “艾司唑仑片
(estazolam tablets)” is used for anti-anxiety and insomnia, and
“氯硝西泮片 (clonazepam tablets)” is for epileptic seizures.
Clearly, the prescriptions do not match the diagnoses.
TABLE I
AN EXAMPLE OF ELECTRONIC MEDICATION RECORD
Name Content
Patient’s ID E20140702E1
Diagnoses
胃癌 (gastric cancer), 气血亏虚 (qi-blood
deficiency), 胃底癌术后
(syndrome and fundus cancer after operation)
Prescriptions
华蟾素注射液 (cinobufacini injection),
参麦注射液 (shenmai injection) (50ml),
养血饮口服液 (yangxueyin oral liquid),
百令胶囊 (bailing capsules),
百士欣胶囊 (Baishixin capsules),
多酶片 (multienzyme tablets),
艾司唑仑片 (estazolam tablets),
氯硝西泮片 (clonazepam tablets),
培菲康胶囊 (bifikang capsules),
香连片(fragrant pills),
宁泌泰胶囊 (ningbitai capsules),
金水宝胶囊 (jinshuibao capsules),
消痛贴膏 (analgesic plaster),
螺旋藻片 (spirulina tablets),
开塞露 (kaiseru).
This type of error was first discussed in [4] by the term
“medication error”, and was categorized with wrong labeling,
dispensing, dose, administration and preparation of drugs.
Since inappropriate actions over drugs may cause severe
damage to patients, researches related to such errors also
belong to “drug safety”. Moreover, the causes of the errors
also owe to inappropriate diagnoses, which leads to part of
the errors falling into the category of “diagnostic error” [5].
Detecting such errors in EHRs is conventionally formulated
as an outlier detection problem. Current researches of out-
lier detection can be generally split into distance-based and
density-based methods [6]. The former is mainly based on
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Nearest Neighbor (NN) to implement a distance-metric for
detection [7], and the latter relies on Local Outlier Factor
(LOF) to assign different degrees for each data sample [8].
In recent years, researchers have been studying and evaluating
different methods regarding to outlier detection, which gives
industrial practitioners valuable insights of choosing different
models [9], [10]. Nevertheless, these studies focus more on
the effectiveness and efficiency of the model than on specific
tasks, and the performances rely on the scale as well as the
distribution of the data [11]. In the meantime, learning the
difference between outliers and normal samples cannot be
done directly from the attributes, and the semantic meanings
of the context should be considered. Taken medical fraud
for example [12], some of the frauds are coding or charging
mistakes which should be excluded, while others like excessive
or irrelevant services are to be detected.
Traditional detection methods in medical domain rely on
experts’ effort to manually identify the errors, which is expen-
sive and of low efficiency. Meanwhile, most of the researches
mainly focus on practice guide [13]. With the developments
in machine learning modeling, current approaches have been
trying to achieve simple and expert-free detection. Schiff et al.
[5] improved clinical decision system with machine learning-
based approach which generates useful alert for medication
error. Later in 2017, they used outlier detection screening to
help generate alerts for medication errors [14]. However, the
performance relies on MedAware system to provide the alert,
and the medication errors are evaluated through chart review
analysis, leading only three out of four alerts valid. Solving
the problem by detecting the mismatches of medical records
in feature space, Zhang et al. [15] proposed an anomaly
detection paradigm based on extended Latent Dirichlet Al-
location (LDA). But the performance relied on the quality of
high dimensional features, and no contextual connection was
considered. Other approaches have been targeting on specific
disease [16], and have not considered the semantic anomaly
that resides in the context of the prescriptions. Taken Table
I for example, “开塞露 (kaiseru)” is used for constipation,
which mismatches with the patients’ diagnoses. However, pa-
tients who have chemotherapy usually suffer from constipation
as a side-effect, and clinicians always add Kaiseru to ease the
pain. Hence, Kaiseru is not a medication error. The situation
is similar to that in medication fraud detection, in which we
cannot simply treat mismatches as anomalies. In the same
time, mining the context of drug corpus has drawn attentions
in recent years [17], which motivates us to detect the errors
through mining the semantic relationship between diagnoses
and prescriptions.
As discussed in previous content, possible causes of the
errors include wrong typing of prescriptions, misuse of the
system, wrong diagnosis, etc. In the following part of the
manuscript, we address the issue as medication anomaly.
Clinical experts identify them based on domain knowledge.
It means there exit certain semantic links among patients, dis-
eases and drugs. Detecting the anomaly requires the machine
to understand the meaning of the text, but current approaches
regarding to natural language processing are mostly used for
correcting syntactic errors [18], [19]. There is clearly a missing
part of adopting NLP techniques to tackle the problem from
the perspective of semantic connections between patients and
drugs. To fill the gap, we were motivated to have the model
learn the semantic inconsistency between the diagnoses and
the prescriptions, and use the model to distinguish possible
medication anomalies.
Following the intuition, we proposed a representation learn-
ing method called Continuous Bag Of Words (CBOW) based
on Ranking Accumulation (CBOWRA) to detect any possible
anomaly in prescriptions. The method uses an Continuous
Bag Of Words (CBOW) model to learn the representation of
context, and an accumulated ranking strategy is included to
help detect possible medication anomaly. The contributions of
the manuscript are three folds.
1) We proposed a simple, yet effective representation learn-
ing method to detect medication anomaly based on pa-
tients’ diagnoses and prescriptions. The training process
of the model is expert-free, which saves considerable
resources for practical adoption.
2) We modified conventional CBOW model in both struc-
ture and training procedure to predict the central word
based on diagnoses. We also incorporate a ranking
mechanism to help exaggerate the differences between
normal drugs and the anomaly.
3) To illustrate the effectiveness of the proposed method,
we designed detection process for non-representation
and representation learning methods. The experimen-
tal results confirmed the superiority of the proposed
method, which further provides insights for adopting
representation learning models in similar scenarios.
The rest of the paper is organized as follows. The detection
scheme, along with the construction of the detection model, are
detailed in Section 2. The evaluations of the proposed method
are conducted on real EHR data in Section 3, in which the
details of data preparing and comparative methods are included
as well. Section 4 presents the discussions regarding to the
proposed method and the conclusions are drawn as Section 5.
II. METHODOLOGY
The outline of the proposed method is given in Fig. 1.
Firstly, the diagnoses and prescriptions of each patient are
vectorized and passed down through a neural-based anomaly
detection model, i.e. CBOWRA, in which the semantic incon-
sistency between diagnoses and prescriptions will be evalu-
ated. The output of the model is a n-length vector, where n
is the number of medications to be evaluated and each entry
represents the possibility of corresponding medication as the
central word. Multiple such groups of data are further passed
to a ranking accumulation process, in which the entries are
sorted in an ascending order. In this manner, the medication
corresponding to the first entry is treated as an anomaly.
To better illustrate the details of the proposed method, we
split the following section into four parts. In subsection A, we
explain the vectorization of the diagnoses and prescriptions,
Diagnoses 
Data
Prescriptions 
Data
Vectorization
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Fig. 1. The outline of medication anomaly detection.
followed by subsection B, which provides a detailed descrip-
tion on the model. Considering the fact that the data are not
in typical document format, we further describe the process of
constructing the training set in subsection C. In the end, the
anomaly detection based on the proposed method is provided.
A. Vectorization of Data
We consider two different codings corresponding to pa-
tients’ diagnoses and prescriptions, respectively. For the for-
mer, we uses multi-hot vector, which is commonly used in
outlier detection methods, to represent the data. Specifically,
each diagnosis is coded into an N -length vector, denoted
as Vpatient i, (i = 1, 2, · · · , k), where k is the number of
patients. Each entry represents the counts of corresponding
disease appearing in the diagnosis. Fig. 2 shows an example
of such vectors.
…
0 1 0 1 1 … 0
1 0 0 0 0 … 1
… … … … … … … …
0 0 0 1 0 … 0
Fig. 2. Examples of vectors for patients’ diagnoses.
As for the prescriptions, we organize raw data into a
different form. Note that CBOW vectorizes the words based on
vocabulary from the corpus. In terms of patients’ prescriptions,
each entry denotes the count number of the patients that have
the medication in their prescriptions. Fig. 3 gives an example
of such vectors for m prescriptions. Note that, the number of
patients that have disease D1 and take drug 2 is 8, so the
entry for D1 of VDrug 2 is 8.
…
0 0 0 0 11 … 3
8 0 1 1 0 … 1
… … … … … … … …
0 13 0 2 0 … 0
Fig. 3. Examples of vectors for patients’ prescriptions.
B. Representation Learning based on CBOW
Representation learning have been proved to be effective
in revealing semantic information such as textual similarity
[20], semantic consistency [21], representations [22] and other
context related features [23]. Hence, we choose such learning
model for mining the semantic inconsistency in patients files.
By evaluating current representation learning methods, in-
cluding CBOW [24], TransE [25], TransH [26], TransD [27],
and TransR [28], we find that CBOW-based model obtained
the best performance of the five. Therefore, we construct our
representation learning model based on CBOW.
The evaluation results can be found in Section III. The
structure of CBOW can be shown as Fig. 4. It is a feed forward
neural network language model, in which non linear hidden
layer is removed, leaving only a projection layer and a softmax
layer [24].
Input
…
Projection
（sum）
Output
（softmax）
Fig. 4. The network structure of CBOW.
The inputs Wt−n,Wt−n+1, · · · ,Wt+n denote the surround-
ing words that are presented in vector forms. The projection
layer does a vector-wise summation of all inputs and passes
the result to a softmax layer to produce the probability of
each candidate word being the central word. The training of
the model can be formulated as maximizing the probability of
generating a correct central word, given by Equation (1).
T∏
t=1
p(wt|w(t−m), · · · , w(t−1), w(t+1), · · · , w(t+m)) (1)
In the equation, w(t−m), · · · , w(t−1), w(t+1), · · · , w(t+m)
are the surrounding words (or context), and wt is the central
word to be predicted. The letter T denotes the size of the
dictionary, i.e. the number of words appeared in the corpus.
2m is the size of the sliding window used for training. The
calculation of the probability p is given as Equation (2), in
which v = {voi, (i = 1, 2, · · · )} represents the vector set of
the surrounding words and uc and ui are the vectors of the
central words.
p(wt|w(t−m), · · · , w(t−1), w(t+1), · · · , w(t+m))
=
exp
[
uTc (vo1 + · · ·+ wo2m)
]
/(2m)∑
i∈v exp
[
uTi (vo1 + · · ·+ wo2m)/(2m)
] (2)
Conventional CBOW has advantages such as light training
burden, high quality word representation and so on. However,
adopting CBOW to specific scenarios requires certain mod-
ifications. In the issue of medication anomaly detection, we
are to consider two different types of documents, namely the
patients-disease and disease-drug.
Intuitively, medication anomaly happens at a relatively
lower frequency when compared with appropriate or correct
prescriptions. Therefore, it is reasonable to assume that the
probability of wrong drug appearing in the diagnoses is lower
than the normal or correct drugs. Since CBOW can predict
the central word based on the context, we can use CBOW
to generate corresponding probabilities for each drug, that
is given to a specific patient, as the central word. Based
on the aforementioned assumption, the medication with the
lowest probability as the central word is most likely to be a
prescription anomaly. Hence, the goal of detecting the anomaly
becomes the detection of non-central words.
In this paper, we modified conventional CBOW into a
multi-layer neural network, whose structure is given in Fig.
5. The first layer is the input layer, where Wt−n, · · · ,Wt+n
…
…
Shared 
Weight
Input
…
…
Embedding
Projection
Dot Production
Layer
Softmax
… …
Fig. 5. Network structure of CBOWRA.
denote the surrounding words and MTar, · · · ,Mneg are the
prescriptions given to the patient. Only surrounding words are
transformed into word embeddings, before passing through a
projection layer. The projection layer works in the same way
as conventional CBOW does, which is to do a vector-wise
summation. The proposed structure differs from conventional
CBOW in the third layer, which performs a dot product
of the output of the projection layer and the vectors of
diseases. In this way, the coded information of the surrounding
words in a specific patient’s diagnoses will be emphasized by
the prescription of the patient. Since the diagnoses and the
prescriptions are vectorized according to the disease, it will
help to identify the semantic inconsistency between a patient’s
diagnoses and prescription. In the end, the output of the third
layer is passed to a softmax layer, and the probabilities of
certain medications as central words are given by each entry
of the output layer.
C. Construction of Training Set
To support the model described in the previous subsection,
preparing the surrounding and central words is the next
problem to solve. It is also well acknowledged that the
disease shares similar or the same symptom(s) across diverse
patients. Therefore, the construction or training of CBOW
model requires to combine different patients’ diagnoses.
Similar to conventional CBOW, we use a sliding window,
the size of which is denoted as 2m in Equation (1) and (2). In
this way, each training sample contains 2m surrounding words
and 1 central word, which are extracted from the diagnoses of
the patients.
For conventional CBOW, the middle word, denoted as wm,
is the central word. However, this is not the case for EHR
data since the diagnoses and prescriptions are organized in a
non-sequential manner. Let the number of medications in the
prescriptions of one patient be n, and the number of diagnoses
of the patient be k. To cope with the proposed method, we
use the following steps to construct the training set.
1) From all the diagnoses of a patient, select m different
diagnoses to combine with the medication. In total, there
will be cmk surrounding words;
2) Choose one drug from the prescription given to one
patient as the central word, and combine it with the
surrounding words generated in step 1).
Note that conventional training process of a neural network
involves updating all the weights, which results in heavy
computing overhead. For example, let the dimension of the
word vector be 300, and the number of words be 20, 000. In
this case, there will be an updating process for a 300×20, 000
matrix. Performing gradient-based training can be very slow
and additional amount of data are required to avoid over-
fitting. To lighten the burden and simplify the training, we
further incorporate negative sampling [29] in the process.
The objective, given as Equation (3), is almost the same as
[29] except the meaning of terms are different.
log σ((v′)Tct,iht,i) +
r∑
x=1
Ecx∼p(x)
[
log σ(−v′)Tct,iht,i
]
(3)
In the equation, ct,i represents the medication, and ht,i is the
context of ct,i in vector form. Negative samples are denoted
as cx. When generating negative samples, we add additional
constraint for non-central words. For example, let Sdrug be
the prescriptions of all patients. The negative samples are
chosen from the set Sdrug −Eyi , based on the corresponding
term frequencies. This is different from “word2vec” model, in
which any non-central word can be a negative sample.
D. Anomaly Detection Based on Ranking Accumulation
With the model properly trained, it is able to predict the
central word with high accuracy. However, solely relying on
predicting the central word to distinguish prescription error
would lead to ambiguous results. Specifically, the CBOW
predicts the central word in a relatively high probability once
training is complete. Fig. 6 is an example of such results,
in which Drug 1 to 3 are normal drugs and Drug 4 is the
anomaly. The model outputs Drug 1 as the central word with
almost 100% probability, leaving the rest of the candidates
close to 0. Note that the medication that is wrongfully given
to a patient is not necessary to be the central word. Instead, it is
the least possible medication that occurs in patients’ diagnosis.
Therefore, the task to detect the anomaly equals to find the
least possible word as the central word. In this case, we can
only rule out Drug 1 as the anomaly, and the rest of the
candidates are still indistinguishable.
Fig. 6. Examples of ranking scores.
To tackle the problem, we applied a ranking strategy, called
Ranking Accumulation (RA), in the process of anomaly de-
tection. For a specific diagnosis, it is intuitive that the smaller
the probability that a drug is predicted to be a normal drug
(central word), the higher the probability that the drug will be
the anomaly. For each training sample, we can generate the
probability of different medications in the output layer. Let
the numbers of surrounding words and diagnosis be m and
n, respectively. We use the following steps to help exaggerate
the difference of probability.
1) Selection of central words: select k medications from
the prescriptions Eyi as E
k and s = n − k negative
candidate drugs as Esneg;
2) Selection of surrounding words: select m different sam-
ples from all diagnoses Dyi as D
m;
3) Ranking the medications: use Dm, Ek and Esneg as
inputs to obtain the probabilities of each candidate
medication as the central word. Use the output value
as the ranking value for each of the candidates;
4) Accumulating the ranking scores: if patients have M
diagnoses, there will be CmM ranking scores in total. By
summing the scores of each medications, the final score
of the drug, denoted as SumRanki. The smaller value
of SumRanki indicates a higher probability of anomaly.
In terms of detecting medication anomaly, k central words
and m − k negative samples were selected from the pre-
scriptions of one patient, while only one central word and
m − 1 negative samples are to be chosen for conventional
CBOW related tasks. In this way, the model can focus on
medication used by patients, rather than influenced by the
negative samples.
III. EXPERIMENTS
A. Datasets and Experimental Setup
All experiments are conducted on a X64 Unix Sever with
a 3.6 GHz i7 CPU and 8GB RAM. Two datasets, namely
SG1213 (cancer patients) and XS1213 (heart failure patients),
are used in the experiments, which are collected by Shuguang
Hospital Affiliated to Shanghai University of Traditional Chi-
nese Medicine and formulated as a structural triple, denoted
as (patient, diagnosis, drugs). Other details of the datasets
are shown as Table II.
TABLE II
DATASETS SPECIFICATION
Dataset No. of Records Patients Diagnosis Drugs
SG1213 970 203 440 578
XS1213 7772 1001 643 1053
Characteristics, such as incompleteness, redundancy, and
diversity, are shared in both datasets, resulting in four major
obstacles in data preprocessing:
1) The symptoms in Traditional Chinese Medicine (TCM)-
related diagnoses and corresponding indications for Chi-
nese patent medicines are relatively macroscopic and
vague, leading to the relations between the two are
not clear. For instance, EHR contains diagnoses like
“气血亏虚 (qi-blood deficiency)” and Chinese patent
medicines like “冬凌草片 (rabdosia rubescens tablets)”;
2) Confusions exits in diagnoses, especially the naming
of specific disease or symptoms. Since the diagnosis
name is typed manually by the doctors, some de-
scriptive sentences are inserted, such as “右肺下叶腺
癌T2N2M1b－IV期, 右肺门 (right lower lobe adeno-
carcinoma stage T2N2M1b-IV, right hilum of lung)”.
The same diagnosis has multiple names, such as “高血
压病2级极高危 (extremely high risk of hypertension
grade 2)”, “高血压2级高危 (hypertension grade 2, high
risk)”, and “高血压病2级中危 (grade 2 medium-risk
hypertension)”, all of which describe the condition “高
血压2级高危 (hypertension of high risk grade 2)”;
3) Coding system are chaotic. Both ICD10 and
TCM codings exist in the data, resulting multiple
codes for a single diagnoses. For example,
E11.900, E11.901, E14.901, E14.900, and E14.900
are coded for the same disease type2diabetesmellitus.
Meanwhile, one specific code may have diverse names
or descriptions. For instance, “支气管扩张伴感染
(bronchiectasis with infection)” and “支气管扩张
(bronchiectasis)” both correspond to the code “J47.01”.
4) Rare drugs increase the difficulties of detecting the
anomaly. Many medications in XS1213 and SG1213
appear in a relatively lower frequency (≤ 3), lead-
ing conventional detection approaches to label them as
anomalies.
In terms of the task described in this paper, we pre-
processed the EHR data by ignoring the hospitalization time,
and integrated diagnoses and prescriptions for each patient
into sets Dyi and Eyi , respectively. The former included all
the diseases while the latter contained all the medications in
the hospital records of the patients.
1) Comparative Methods: For distance-based methods,
LOF was used to cluster the patients based on their diagnoses
and prescriptions. The larger the LOF value is, the more likely
the corresponding medication is the anomaly.
For Naive Bayes (NB), we use two different settings.
One is conventional NB, which assume that the diseases are
independent. In this case, all the diagnoses and prescriptions
are used to calculate the probabilities. However, considering
that some diseases co-occur, we only use the diagnoses and
prescriptions that frequently appear in the data. We call this
setting NB+(i), where i = 1, · · · , 5, to distinguish with the
conventional NB.
For TransE, we define three relations as “has disease”,
“has medicine” and “Corr”, which are used to describe the
relations between disease, medication and patients. We use the
diagnosis as the head entity (h), the medication as the tail (t),
and the relation (r) has h+ r = t. Distance between diagnose
and prescriptions are calculated using the minimum value of
all the distances between head and tail entities. Similar settings
are also used for other Trans-series methods.
2) Parameter Setting: The parameters of the proposed
method are shown in Table III. We evaluated different number
of surrounding words ranging from 1 to 10, and noted that,
after k > 3, the performance remained still.
TABLE III
PARAMETER SETTINGS
Parameter Value
No. of
Surrounding Words
2
No. of Negative Samples 5
No. of Central Words 1
No. of Diseases 64
3) Naming Formalization: In this paper, we deleted the
descriptive words related to stages and transformed the data
into the form, saying “左乳腺癌术后 (after left breast cancer
surgery)” and “右肺下叶腺癌 (right lower lobe adenocarci-
noma of lung)”. Similarly, hypertension is often described with
a classification and risk degree, such as “grade II”, “medium
risk” and “high risk”, which we unified into “hypertension”.
Other unifications are listed in Table IV.
4) Medication Screening: Some of the medications, eg.
“氯化钠针 (sodium chloride needles)”, appeared in almost
every prescription given to patients, which we believe is
TABLE IV
UNIFIED NAME FOR PATIENTS’ DIAGNOSES
Unified Name Original Name
1
冠心病
( coronary heart disease)
冠状动脉粥样硬化性心脏病
(Coronary atherosclerotic
heart disease)
2
高血压
( Hypertension)
高血压3期（极高危）
(Hypertension Phase 3,
Extremely High Risk),
高血压病2级
(Hypertension Class 2)
3
慢性心功能不全
(Chronic cardiac
insufficiency)
慢性心功能不全
心功能III级(NYHA分级)
(Class III of Chronic
Cardiac Insufficiency (NYHA))
most unlikely to be the anomaly. Therefore, we remove these
records in the preprocessing of the dataset. Meanwhile, some
medications (eg. “脉络宁针(mailuoning needle)” and “脉络
宁注射液(mailuoning injection)”) are given in diverse forms
which should be unified (eg. “脉络宁针(mailuoning needle”)
as well.
In order to evaluate the performance, we constructed an
artificial standard answer set. Firstly, we obtained the cor-
responding indications for all drugs from the pharmacopeia
website, before comparing the indications with the diagnoses
of the patients. Finally, the indications for each drug that did
not match the patients’ diagnoses were regarded as abnormal
drugs and were put into the standard answer set. Experienced
doctors are included to help ensure the accuracy of the set.
5) Evaluation Criteria: Note that, for all the comparing
methods, the outputs are lists of probabilities indicating the
corresponding medications being the anomalies. To evaluate
the performances, we choose TopN accuracy, denoted as
Equation (4), which represents the percentage of anomalies
exist in the first N drugs. The letter t in the equation is the
number of anomalies detected by the methods, and TN is the
number of all anomalies in the prescriptions. By setting the
values of N ranging from 1 to 5, we can evaluate the accuracy
of the methods in different granularities.
TopN =
t
TN
(4)
B. Experimental Results
The Top N accuracies on SG1213 and XS1213 are pre-
sented in Table V and VI, respectively. The proposed method,
denoted as “CBOWRA”, possesses the highest accuracy (over
0.84) in all settings, Between the performances on two
datasets, all methods on XS1213 performs slightly poor than
on SG1213. We think the reason are two folds: The first is
that medication are more diverse on XS1213 than on SG1213;
The second is that the drugs with appearance less than 3
occupy a higher portion in XS1213. The two reasons lead
to an insufficient training of the models, thereby causes the
performance to be less satisfying in XS1213.
TABLE V
TOP N ACCURACIES ON SG1213
Method Top 1 Top 2 Top 3 Top 4 Top 5
LOF 0.740 0.759 0.763 0.767 0.773
NB 0.410 0.405 0.456 0.498 0.528
NB+(1) 0.750 0.758 0.766 0.784 0.789
NB+(2) 0.755 0.775 0.792 0.796 0.793
NB+(3) 0.770 0.773 0.767 0.768 0.774
NB+(4) 0.690 0.695 0.688 0.696 0.699
NB+(5) 0.635 0.643 0.637 0.640 0.642
TransE 0.710 0.708 0.696 0.682 0.673
TransH 0.655 0.685 0.688 0.684 0.682
TransD 0.664 0.674 0.680 0.677 0.673
TransR 0.663 0.659 0.650 0.645 0.638
CBOWRA 0.879 0.867 0.858 0.851 0.844
In the results of NB, we also found that the model with K =
2 achieves the best performance, which gave us insights to set
a proper length of surrounding words. In the experiments, we
set the length of surrounding words to 2 when training CBOW
related methods.
TABLE VI
TOP N ACCURACIES ON XS1213
Method Top 1 Top 2 Top 3 Top 4 Top 5
LOF 0.599 0.596 0.611 0.613 0.617
NB 0.434 0.543 0.544 0.560 0.561
NB+(1) 0.629 0.620 0.616 0.611 0.612
NB+(2) 0.607 0.615 0.610 0.610 0.608
NB+(3) 0.605 0.609 0.606 0.604 0.599
NB+(4) 0.616 0.611 0.599 0.596 0.593
NB+(5) 0.615 0.595 0.594 0.592 0.593
TransE 0.620 0.625 0.621 0.616 0.611
TransH 0.619 0.621 0.622 0.617 0.613
TransD 0.575 0.591 0.592 0.595 0.598
TransR 0.638 0.623 0.620 0.618 0.613
CBOWRA 0.639 0.631 0.627 0.624 0.622
When using CBOW to cluster similar patients, the patient
vectors are coded in multi-hot forms, with dimensions of 326
(SG1213) and 643 (XS1213), respectively. However, there are
only 15 diagnoses per patient on average, which makes the
sparseness of patient vectors reach 95% and 97%, respectively.
Sparse vectors seriously affect the performance of clustering
and the accuracy of the detection will be further reduced.
Trans-series is suitable for dealing with data with various
kinds of relationships. However, there are only three kinds of
entities in both of the datasets, namely “patient”, “medication”,
and “diagnosis”, and two kinds of relationships between
entities, namely the relationship between patients and drugs
and the one between patients and diagnoses. In addition, the
relationships between entities are one-to-many, many-to-one,
and many-to-many, which make the model ineffective. For
example, with training data 〈PatientA,Has drug,Drug1〉,
〈PatientA,Has drug,Drug2〉, both of them have the same
head entity (h) and relation (r). TransE tends to treat the two
tail entities, namely Drug1 and Drug2, as the same entity,
which reduces the accuracy of the model and confuses correct
and abnormal drugs.
IV. DISCUSSION
In the experiments, the proposed method has achieved
competitive performance in all settings. However, the datasets
only contain two medical concepts, namely diagnosis and med-
ication, and the performances on specific diagnoses are still
less satisfying. By analyzing the data and the aforementioned
results, we summarize the reasons as follows.
1) Considerable amount of the prescriptions are injec-
tions, which are commonly used for surgical hemostasis,
analgesia, suppression of side effects of radiotherapy
and chemotherapy, and adjuvant therapy. The data only
appear in the EHR when doctors are operating on the
patients, and record in a non-real time manner. Mean-
while, doctors usually do not record the symptoms of
patients during surgery, nor do they record whether they
have undergone radiotherapy or chemotherapy. There-
fore, these medications are classified to be the anomaly,
despite the fact they are indeed appropriate medications
and appear in almost every patient’s prescription.
2) In the datasets, some anti-side-effect medications are
considered to be anomalies because they do not have
direct connection with the disease. For example, patients
treated with chemotherapy or radiotherapy have consti-
pation as a side effect. In the dataset, suppositories glyc-
erol, which is used to treat the symptom, is labeled as
an anomaly. However, with the proposed model trained
to discover semantic consistency over the diagnosis and
prescription, these medications are identified as normal
drugs. Therefore, some of the mismatches confirms the
effectiveness of the proposed method.
3) Some patients use rare drugs. By “rare”, it means
there are few people using this kind of drug and they
should not be considered as an anomaly as other outlier
detection methods do. Due to insufficient data volume,
the proposed model fails to distinguish such medication
from the true anomaly.
The future work lies in two aspects. The first is to improve
the construction of standard answers. In the paper, we used
the relevant knowledge on encyclopedia websites and a string
similarity matching method in the construction. However, it
does not rule out factors such as low accuracy, incomplete
information, and poor timeliness of medical knowledge, all
of which can interfere with the accuracy of standard answers.
The other extension of the work is to use information, such
as patient examinations and operations, to enrich the context
of prescriptions, which we believe will further improve the
medication anomaly detection.
V. CONCLUSION
In this manuscript, we present a simple, yet effective
method, i.e. CBOWRA, to detect possible medication anomaly
in EHR systems, which adopts representation learning to
reveal the semantic consistency between diagnoses and pre-
scriptions in patients’ files. Specifically, we combine CBOW
and a ranking accumulation strategy to construct the model,
and evaluate the performances with other methods ranging
from conventional outlier detection to recent representation
learning approaches. The experimental results of the proposed
method outperforms the others by over 3.91% and 0.68%
in two real hospital data, respectively. In addition, we also
discussed the possible improvements and future directions for
the proposed method.
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